Kamke Trent G, Senior Vice President of Operations, has demonstrated a clear pattern of insider trading activity focused exclusively on LeMaitre Vascular, Inc. (LMAT), as reflected in SEC Form 4 filings. Over the course of 30 transactions, Kamke has engaged in both buying and selling, though the overall trend leans heavily toward divestment. Total buy activity amounts to $193,153.41, while total sell activity significantly outweighs this at $449,873.61. This disparity underscores a net reduction in Kamke’s holdings in LMAT over time.
Recent activity further highlights this selling bias. On March 11, 2026, Kamke executed a substantial sale of LMAT shares valued at $284,812.50, followed by another sale on February 27, 2026, totaling $115,142.76. These transactions, coupled with earlier sales and minimal recent buying activity, suggest a strategic reduction in exposure to LMAT stock. Notably, many filings include transactions coded as "A" (award) or "M" (merger), which often represent non-market transfers such as stock grants or conversions, but these do not offset the significant cash value of the outright sales.
Kamke’s trading history reveals a consistent focus on LMAT, with no diversification into other companies. The recent emphasis on selling, particularly in early 2026, indicates a deliberate shift in portfolio management. While the reasons behind these transactions remain undisclosed, the data paints a clear picture of a senior executive steadily reducing their stake in LeMaitre Vascular.
AI-assisted summary